Adamis Pharmaceuticals (ADMP) Stock Price Up 18.8%

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)’s share price rose 18.8% during trading on Wednesday . The company traded as high as $5.05 and last traded at $4.75. Approximately 2,331,800 shares changed hands during mid-day trading, an increase of 216% from the average daily volume of 737,005 shares. The stock had previously closed at $4.00.

ADMP has been the topic of a number of research reports. B. Riley restated a “buy” rating and issued a $9.50 price objective on shares of Adamis Pharmaceuticals in a report on Wednesday, October 4th. Zacks Investment Research downgraded Adamis Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Monday, November 20th. ValuEngine downgraded Adamis Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Tuesday, October 3rd. Maxim Group reiterated a “buy” rating and set a $13.00 target price on shares of Adamis Pharmaceuticals in a report on Monday, August 21st. Finally, Raymond James Financial assumed coverage on Adamis Pharmaceuticals in a report on Tuesday, September 12th. They set an “outperform” rating and a $7.00 target price on the stock. Two analysts have rated the stock with a sell rating and three have assigned a buy rating to the company. Adamis Pharmaceuticals has a consensus rating of “Hold” and an average price target of $10.33.

The company has a debt-to-equity ratio of 0.06, a quick ratio of 3.79 and a current ratio of 3.93.

Several large investors have recently made changes to their positions in ADMP. IFP Advisors Inc raised its holdings in shares of Adamis Pharmaceuticals by 2,245.6% during the 2nd quarter. IFP Advisors Inc now owns 34,433 shares of the specialty pharmaceutical company’s stock valued at $179,000 after buying an additional 32,965 shares during the period. Sterling Global Strategies LLC raised its holdings in shares of Adamis Pharmaceuticals by 66.5% during the 2nd quarter. Sterling Global Strategies LLC now owns 70,934 shares of the specialty pharmaceutical company’s stock valued at $369,000 after buying an additional 28,334 shares during the period. Leisure Capital Management raised its holdings in shares of Adamis Pharmaceuticals by 7.2% during the 2nd quarter. Leisure Capital Management now owns 145,909 shares of the specialty pharmaceutical company’s stock valued at $759,000 after buying an additional 9,832 shares during the period. Wells Fargo & Company MN purchased a new stake in shares of Adamis Pharmaceuticals during the 2nd quarter valued at about $169,000. Finally, Northern Trust Corp raised its holdings in shares of Adamis Pharmaceuticals by 5.5% during the 2nd quarter. Northern Trust Corp now owns 51,108 shares of the specialty pharmaceutical company’s stock valued at $266,000 after buying an additional 2,686 shares during the period. Institutional investors and hedge funds own 16.73% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first published by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/06/adamis-pharmaceuticals-admp-stock-price-up-18-8.html.

Adamis Pharmaceuticals Company Profile

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M).

What are top analysts saying about Adamis Pharmaceuticals Corp? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Adamis Pharmaceuticals Corp and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit